Products
Ranevetmab Biosimilar Canine Monoclonal Antibody (NGF) for Research
Pre-Made Ranevetmab biosimilar, Canine Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Ranevetmab is a caninized monoclonal antibody that can be potentially used in the treatment of Osteoarthritis (OA). Specific Inquiry.
Order Information
| Catalog No. | Package | Price(In USD) |
|---|---|---|
| GMP-Bios-ab-469-1mg | 1mg | 3090 |
| GMP-Bios-ab-469-10mg | 10mg | |
| GMP-Bios-ab-469-100mg | 100mg | |
| GMP-Bios-ab-469-xmg | ＞100mg |
Product Details
| Products Name (INN Index) | Pre-Made Ranevetmab biosimilar, Canine Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody |
| INN Name | Ranevetmab |
| Target | NGF |
| Format | Canine Whole mAb |
| Derivation | Caninized |
| Species Reactivity | Canine |
| CH1 Isotype | IgG1 |
| VD LC | Kappa |
| Highest_Clin_Trial (Jan '20) | Unknown |
| Est. Status | Active |
| 100% SI Structure | None |
| 99% SI Structure | None |
| 95-98% SI Structure | None |
| Year Proposed | 2016 |
| Year Recommended | 2017 |
| Companies | Nexvet |
| Conditions Approved | na |
| Conditions Active | Osterarthritis |
| Conditions Discontinued | na |
| Development Tech | PETization Technology |
About target - NGFB
1. Protein Beta-nerve growth factor
2. Gene NGFB
3. Organism Homo sapiens (Human)
Function
Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems (PubMed:14976160, PubMed:20978020).
Extracellular ligand for the NTRK1 and NGFR receptors, activates cellular signaling cascades to regulate neuronal proliferation, differentiation and survival (PubMed:20978020) (Probable).
The immature NGF precursor (proNGF) functions as ligand for the heterodimeric receptor formed by SORCS2 and NGFR, and activates cellular signaling cascades that lead to inactivation of RAC1 and/or RAC2, reorganization of the actin cytoskeleton and neuronal growth cone collapse. In contrast to mature NGF, the precursor form (proNGF) promotes neuronal apoptosis (in vitro) (By similarity).
Inhibits metalloproteinase-dependent proteolysis of platelet glycoprotein VI (PubMed:20164177).
Binds lysophosphatidylinositol and lysophosphatidylserine between the two chains of the homodimer. The lipid-bound form promotes histamine relase from mast cells, contrary to the lipid-free form (By similarity).
